<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR11">
 <label>11.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Orlowski</surname>
    <given-names>RZ</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies</article-title>
  <source>J. Clin. Oncol.</source>
  <year>2002</year>
  <volume>20</volume>
  <fpage>4420</fpage>
  <lpage>4427</lpage>
  <pub-id pub-id-type="doi">10.1200/JCO.2002.01.133</pub-id>
  <?supplied-pmid 12431963?>
  <pub-id pub-id-type="pmid">12431963</pub-id>
 </element-citation>
</ref>
